Present & future of cancer #Immunotherapy: evidence suggests that pts not responding to PD-1/PD-L1-targeted agents do not have PD-L1-expressing tumoursRead more on the ESMO Daily Reporter & don’t miss the #ESMO20 Keynote Lecture by Lieping Chen (17/10) http://ow.ly/UK5550BTbQP
An immuno tease.
LAG525 Solid and Hematologic Malignancies trial completed, page-38
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.0¢ |
Change
0.010(3.57%) |
Mkt cap ! $421.8M | |||
| Open | High | Low | Value | Volume |
| 28.0¢ | 29.0¢ | 27.5¢ | $814.3K | 2.871M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 186340 | 27.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.5¢ | 136417 | 6 |
View Market Depth
| Last trade - 16.10pm 06/11/2024 (20 minute delay) ? |
| IMM (ASX) Chart |